Lau Associates’s Biogen BIIB Stock Holding History

Lau Associates’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.07M	Hold	3,608	–	–	0.53%	47
2019 Q3	$840K	Sell	3,608 -1,500	-29%	-$349K	0.44%	54
2019 Q2	$1.2M	Hold	5,108	–	–	0.57%	46
2019 Q1	$1.21M	Hold	5,108	–	–	0.62%	45
2018 Q4	$1.54M	Buy	5,108 +518	+11%	+$165K	0.85%	33
2018 Q3	$1.62M	Hold	4,590	–	–	0.92%	37
2018 Q2	$1.33M	Hold	4,590	–	–	0.91%	38
2018 Q1	$1.26M	Buy	4,590 +170	+4%	+$52.8K	0.98%	41
2017 Q4	$1.41M	Buy	4,420 +50	+1%	+$16K	1.1%	34
2017 Q3	$1.37M	Sell	4,370 -50	-1%	-$14.8K	1.06%	32
2017 Q2	$1.2M	Hold	4,420	–	–	0.96%	39
2017 Q1	$1.21M	Buy	4,420 +50	+1%	+$14.1K	1.08%	34
2016 Q4	$1.24M	Sell	4,370 -400	-8%	-$119K	1.25%	29
2016 Q3	$1.49M	Hold	4,770	–	–	1.52%	20
2016 Q2	$1.15M	Sell	4,770 -200	-4%	-$52.7K	1.21%	32
2016 Q1	$1.29M	Buy	4,970 +50	+1%	+$13.2K	1.34%	25
2015 Q4	$1.51M	Buy	4,920 +1,200	+32%	+$345K	1.62%	20
2015 Q3	$1.09M	Buy	3,720 +1,880	+102%	+$621K	1.28%	26
2015 Q2	$743K	Hold	1,840	–	–	0.73%	34
2015 Q1	$777K	Buy	1,840 +200	+12%	+$78.8K	0.74%	34
2014 Q4	$557K	Buy	+1,640	New	+$531K	0.51%	41

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lau Associates's BIIB Position: Q4 2019 in Review

Lau Associates held its Biogen (BIIB) position steady in Q4 2019 at 3,608 shares worth $1.07M. The position accounts for 0.53% of the portfolio, ranked #47.

Lau Associates first reported a position in BIIB in Q4 2014 and has held it in 21 quarters since. The position peaked at $1.62M in Q3 2018. 1,102 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

Lau Associates held 3,608 shares of Biogen worth $1.07M as of Q4 2019.
Lau Associates left its Biogen share count unchanged in Q4 2019.
Biogen made up 0.53% of Lau Associates's portfolio in Q4 2019, its #47 holding.
Lau Associates first reported a position in Biogen in Q4 2014 and has held it in 21 quarters since.
Lau Associates's Biogen position peaked at $1.62M in Q3 2018.
1,102 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.